SVB Leerink Lowered Moderna(NASDAQ:MRNA) Price Target From $111 to $93.

By / / Moderna

SVB Leerink Downgraded Moderna(NASDAQ:MRNA) From Market Perform to Underperform and Lowered Its Price Target From $111 to $93.

Scroll to Top